Endocrine Abstracts

BackgroundNatural disasters resulting in psychosocial stress and endocrine imbalances are implicated for impacting sexual health. We postulate COVID-19 for its longer duration and global lockdown has implications on the sexual healthMethodsWe analysed contemporary protocols of six ongoing trials through WHO International Clinical Trials Registry Platform and www.clinicaltrials.gov trials registry database. Th...

Introduction: US Food and Drug Administration (FDA) has recently approved bexagliflozin, a new SGLT2 inhibitor. We examined the outcomes and metabolic effects of Bexagliflozin across the published Randomised Controlled Trials (RCCTs)Methods: A comprehensive literature search was done to extract publications from Medline-PubMed and Cochrane library, since inception till January 20, 2023, then screened and reviewed by two independent reviewers. Data includ...